We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Warning Cites Violations Related to Propofol
Teva Warning Cites Violations Related to Propofol
May 3, 2010
Teva Parenteral Medicines has received an FDA warning letter for GMP violations — some related to its anesthetic propofol injectable emulsion.